Announced Fri, 26 Jun · 18:26 IST
Subsidiary gets drug license suspension for three stores
General View source PDF
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.7%1-day move
₹839.00
prior close
₹842.35
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.1-1.2-1.6-1.1-3.7-2.6-2.3-1.9-2.6-3.0-4.5———
Up moveDown movePending
AI summary
Subsidiary Optival Health Solutions received three drug license suspension orders from Drug Control Administration authorities. One Hubli Karnataka store suspended for 1 day, one Gadag Karnataka store for 2 days, and one Serilingampally Andhra Pradesh store for 3 days. Orders issued under Rule 65 of Drugs and Cosmetics Act 1940. Combined potential revenue loss of about Rs 1.58 lakh. Orders received on 25 June 2026.
Likely market impact
Financial impact is minimal at about Rs 1.58 lakh total revenue loss across three stores. Negligible effect on overall business.